Manufacturing, Biologic Drugs

GE Healthcare Life Sciences, Akeso Pharmaceuticals to Accelerate Novel Therapy Manufacturing in China

November 07, 2019

GE Healthcare Life Sciences will supply Akeso Pharmaceuticals with the FlexFactory platform to accelerate production of antibody drugs in the Guangzhou region.

GE Healthcare Launches Viral Vector-Based Gene Therapy Manufacturing

October 28, 2019

GE Healthcare Life Sciences’ KUBio box is an integrated, flexible biomanufacturing environment for viral vector-based gene therapies.

GE Healthcare, CPI, and Cobra Biologics Introduce New AAV Purification System

October 24, 2019

The partners have developed a scalable, cost-effective purification process for adeno-associated viruses.

Sanofi Opens New Digital Manufacturing Facility in Massachusetts

October 16, 2019

The new location is one of the world’s first digital facilities to use intensified, continuous biologics production technology.

Lonza, Genmab Extend Drug Development Partnership

October 15, 2019

Lonza, through its Ibex Solutions, will now cover preclinical and clinical development and manufacturing for a significant portion of Genmab’s pipeline.

Tracking Raw Materials in Biopharma Manufacturing

October 02, 2019

Automated, electronic systems for raw materials tracking improve efficiency and prevent mistakes in biopharma manufacturing.

GSK Invests $120 million in US Biopharmaceutical Manufacturing Facility

September 26, 2019

GSK’s expanded R&D and manufacturing facility in Upper Merion, PA houses a new analytical lab and flexible manufacturing equipment, including single-use bioreactors.

BIA Separations Launches AAV Process Development Service to Accelerate Gene Therapy Production

September 19, 2019

The new program, Cornerstone, integrates process development expertise and novel technology to remove development bottlenecks in the manufacture of gene therapy medicinal products.

Nephron, UofSC Researchers Collaborate on Automation

September 16, 2019

Nephron Pharma and the University of South Carolina plan to build a sterile compounding lab at the University for research and training.

GSK Announces First Biologic for the Treatment of Eosinophilic Asthma in Pediatric Patients

September 13, 2019

FDA approved the drug after a successful open-label study of children aged six to 11 years and living with the condition.